DNA test
FDA Approves Marketing of DNA Test for Cancer Predisposition
2023-10-03 20:02:44
by
Dan McCue
WASHINGTON — The Food and Drug Administration has granted de novo marketing authorization for the Invitae Common Hereditary Cancers Panel, an in vitro diagnostic test that can help detect hundreds of genetic variants associated with an elevated risk of developing... Read More
Straight From The Well
